SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs India informs about Board meeting

22 Sep 2015 Evaluate

Parenteral Drugs India has informed that a meeting of the Board of Directors of the Company will be held on September 30, 2015, to consider the allotment of 0% Non-cumulative, Non-convertible, Redeemable Preference Shares of the Company and other items as per agenda of the meeting. Also, according to Schedule B the SCBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company’s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares, the ‘Trading Window’ of the Company shall remain closed from September 22, 2015 to October 02, 2015 and will open on October 03, 2015 for insiders accordingly.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×